期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
To investigate the effect of Shenqi Tiaoshen Formula on CSE induced inflammatory response of MH-S cells based on TLR4/NF-kB/NLRP3 pathway
1
作者 Wang Hui Yang Qin-jun +4 位作者 ZHOU Fan-chao Yang Cheng TONG Jia-bing LI Ze-geng 《Journal of Hainan Medical University》 CAS 2023年第17期15-20,共6页
Objective:To study the effects of Shenqi Tiaoshen Formula(SQTS)on the inflammatory response of MH-S cells induced by cigarette smoking extract(CSE)and its mechanism based on TLR4/NF-kB/NLRP3 pathway.Methods:MH-S cells... Objective:To study the effects of Shenqi Tiaoshen Formula(SQTS)on the inflammatory response of MH-S cells induced by cigarette smoking extract(CSE)and its mechanism based on TLR4/NF-kB/NLRP3 pathway.Methods:MH-S cells were used as subjects to evaluate cell viability by CCK-8 method.The levels of TNF-α,IL-1βand IL-6 in the supernatant were detected by ELISA.ROS were detected by DCFH-DA fluorescence probe.Western blotting was used to detect the expression of TLR4/NF-kB/NLRP3 pathway protein,and TAK-242,a TLR4 inhibitor,was used to verify the role of SQTS in the TLR4/NF-kB/NLRP3 pathway.Results:Compared with blank group,the cell survival rate of CSE group was decreased,and the contents of inflammatory cytokines TNF-α,IL-1βand IL-6 were increased(P<0.05),ROS fluorescence expression level was significantly increased(P<0.01),TLR4/NF-kB/NLRP3 pathway protein expression was significantly increased(P<0.05);Compared with CSE group,the survival rate of cells in SQTS groups was increased,and the expression levels of the above indexes were decreased(P<0.05),and TLR4/NF-kB/NLRP3 pathway protein decreased in TAK-242 groups(P<0.05).Conclusion:SQTS can reduce the inflammatory response of MH-S cells induced by CSE by inhibiting TLR4/NF-kB/NLRP3 pathway. 展开更多
关键词 Shenqi Tiaoshen Formula CSE MH-S cells tlr4/NF-kB/nlrp3 signaling pathway Inflammation
下载PDF
宣肺败毒方调控TLR4/NLRP3/Caspase1信号通路抗小鼠急性肺损伤的作用机制研究
2
作者 邱先哲 黄晨瑶 +8 位作者 李彩霞 张淑坤 崔立华 李雯雯 刘国敬 齐育麟 张晗 李琳 李玉红 《天津中医药大学学报》 CAS 2024年第11期992-999,共8页
[目的]基于Toll样受体4(TLR4)/核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)/半胱氨酸蛋白酶-1(Caspase1)信号通路研究宣肺败毒方(XFBD)对IgG免疫复合物(IgG-IC)诱导小鼠急性肺损伤(ALI)的药效作用及机制研究。[方法]采用IgG-IC诱导小鼠构... [目的]基于Toll样受体4(TLR4)/核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)/半胱氨酸蛋白酶-1(Caspase1)信号通路研究宣肺败毒方(XFBD)对IgG免疫复合物(IgG-IC)诱导小鼠急性肺损伤(ALI)的药效作用及机制研究。[方法]采用IgG-IC诱导小鼠构建ALI模型,灌胃XFBD 4 g生药/kg和8 g生药/kg,单次给药;苏木素-伊红染色法(HE)观察肺组织病理变化;乳酸脱氢酶(LDH)试剂盒测定细胞活力;荧光定量PCR法检测小鼠肺组织细胞因子白细胞介素-6(IL-6)、白细胞介素-18(IL-18)、白细胞介素-1β(IL-1β)、单核细胞趋化蛋白-1(MCP-1)以及TLR4/NLRP3/Caspase1信号通路相关因子mRNA表达量;免疫组化法检测小鼠肺组织TLR4、NLRP3和消皮素D(GSDMD)蛋白表达;蛋白免疫印迹法检测小鼠肺组织闭合蛋白(Occludin)、闭锁连接蛋白1(ZO-1)以及TLR4/NLRP3/Caspase1信号通路相关因子蛋白表达水平。[结果]与正常组相比,模型组小鼠肺组织炎性细胞浸润,肺泡间隙增厚,肺组织病理损伤评分和肺组织脏器系数显著升高,LDH及细胞因子表达明显升高,Occludin和ZO-1表达下调,TLR4/NLRP3/Caspase1信号通路相关因子mRNA和蛋白水平显著升高;与模型组相比,XFBD显著缓解急性肺损伤小鼠肺组织炎症细胞浸润,降低细胞因子表达,上调Occludin和ZO-1,显著下调TLR4/NLRP3/Caspase1信号通路相关因子mRNA和蛋白水平。[结论]XFBD可通过调控TLR4/NLRP3/Caspase1信号通路发挥抗小鼠ALI的作用。 展开更多
关键词 宣肺败毒方 急性肺损伤 tlr4/nlrp3/caspase1信号通路 炎症
下载PDF
Huoxin Pill Reduces Myocardial Ischemia Reperfusion Injury in Rats via TLR4/NFκB/NLRP3 Signaling Pathway 被引量:4
3
作者 CAO Ce QI Yu-tong +5 位作者 WANG Ao-ao WANG Zi-yan LIU Zi-xin MENG Hong-xu LI Lei LIU Jian-xun 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2023年第12期1066-1076,共11页
Objective:To explore the protective effect of Huoxin Pill(HXP)on acute myocardial ischemia-reperfusion(MIRI)injury in rats.Methods:Seventy-five adult SD rats were divided into the sham-operated group,model group,posit... Objective:To explore the protective effect of Huoxin Pill(HXP)on acute myocardial ischemia-reperfusion(MIRI)injury in rats.Methods:Seventy-five adult SD rats were divided into the sham-operated group,model group,positive drug group(diltiazem hydrochloride,DH),high dose group(24 mg/kg,HXP-H)and low dose group(12 mg/kg,HXP-L)of Huoxin Pill(n=15 for every group)according to the complete randomization method.After 1 week of intragastric administration,the left anterior descending coronary artery of the rat's heart was ligated for 45 min and reperfused for 3 h.Serum was separated and the levels of creatine kinase(CK),creatine kinase isoenzyme(CK-MB)and lactate dehydrogenase(LDH),superoxide dismutase(SOD),and malondialdehyde(MDA),hypersensitive C-reactive protein(hs-CRP)and interleukin-1β(IL-1β)were measured.Myocardial ischemia rate,myocardial infarction rate and myocardial no-reflow rate were determined by staining with Evans blue and 2,3,5-triphenyltetrazolium chloride(TTC).Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP)and Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine(BATMAN)databases were used to screen for possible active compounds of HXP and their potential therapeutic targets;the results of anti-inflammatory genes associated with MIRI were obtained from GeneC ards,Drugbank,Online Mendelian Inheritance in Man(OMIM),and Therapeutic Target Datebase(TTD)databases was performed;Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment were used to analyze the intersected targets;molecular docking was performed using AutoD ock Tools.Western blot was used to detect the protein expression of Toll-like receptor 4(TLR4)/nuclear factor kappa-B(NFκB)/NOD-like receptor protein 3(NLRP3).Results:Compared with the model group,all doses of HXP significantly reduced the levels of LDH,CK and CK-MB(P<0.05,P<0.01);HXP significantly increased serum activity of SOD(P<0.05,P<0.01);all doses of HXP significantly reduced the levels of hs-CRP and IL-1β(P<0.05,P<0.01)and the myocardial infarction rate and myocardial no-reflow rate(P<0.01).GO enrichment analysis mainly involved positive regulation of gene expression,extracellular space and identical protein binding,KEGG pathway enrichment mainly involved PI3K-Akt signaling pathway and lipid and atherosclerosis.Molecular docking results showed that kaempferol and luteolin had a better affinity with TLR4,NFκB and NLRP3 molecules.The protein expressions of TLR4,NFκB and NLRP3 were reduced in the HXP group(P<0.01).Conclusions:HXP has a significant protective effect on myocardial ischemia-reperfusion injury in rats,and its effect may be related to the inhibition of redox response and reduction of the inflammatory response by inhibiting the TLR4/NFκB/NLRP3 signaling pathway. 展开更多
关键词 Houxin Pill myocardial ischemia-reperfusion injury tlr4/NFκB/nlrp3 signaling pathway network pharmacology molecular docking
原文传递
Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease 被引量:4
4
作者 Mao-xing Pan Chui-yang Zheng +7 位作者 Yuan-jun Deng Kai-rui Tang Huan Nie Ji-qian Xie Dong-dong Liu Gui-fang Tu Qin-he Yang Yu-pei Zhang 《Journal of Integrative Medicine》 SCIE CAS CSCD 2021年第5期428-438,共11页
Objective: High-fat diet(HFD) and inflammation are two key contributors to nonalcoholic fatty liver disease(NAFLD). Shenling Baizhu powder(SLBZP), a classical herbal compound, has been successfully used to alleviate N... Objective: High-fat diet(HFD) and inflammation are two key contributors to nonalcoholic fatty liver disease(NAFLD). Shenling Baizhu powder(SLBZP), a classical herbal compound, has been successfully used to alleviate NAFLD. However, its specific mechanisms are not fully understood. In this study, we assessed the anti-NAFLD effect of SLBZP in vivo.Methods: Rats were fed an HFD with or without SLBZP or with probiotics. At the end of week 16, an echo magnetic resonance imaging(EchoMRI) body composition analyser was used to quantitatively analyse body composition;a micro-computed tomography(micro-CT) imaging system was used to evaluate whole body and liver fat;and the Moor full-field laser perfusion imager 2 was used to assess liver microcirculation, after which, all rats were sacrificed. Then, biochemical indicators in the blood and the ultrastructure of rat livers were evaluated. Protein expression related to the liver Toll-like receptor 4(TLR4)/Nod-like receptor family pyrin domain-containing 3(NLRP3) signalling pathway was assessed using Western blot analysis. Further, high-throughput screening of 29 related inflammatory factors in liver tissue was performed using a cytokine array.Results: SLBZP supplementation reduced body weight, serum free fatty acid, and insulin resistance index(P<0.05). It also ameliorated liver microcirculation and ultrastructural abnormalities. EchoMRI and micro-CT quantitative analyses showed that treatment with SLBZP reduced fat mass and visceral fat(P<0.05 and P<0.01, respectively). In addition, SLBZP decreased the expression of lipopolysaccharide(LPS)-activated TLR4/NLRP3 signalling pathway-related proteins and altered the expression levels of some inflammatory cytokines in liver tissues.Conclusion: SLBZP can inhibit NLRP3 inflammasome activation and interleukin-1 b release by suppressing LPS-induced TLR4 expression in rats with HFD-induced NAFLD. Thus, SLBZP may be beneficial for the prevention and treatment of inflammatory damage and associated diseases. 展开更多
关键词 Nonalcoholic fatty liver disease Shenling Baizhu powder Traditional Chinese medicine tlr4/nlrp3 signalling pathway
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部